A startup selling elective whole-body scans for upward of $1,000 is launching a 10-year, 100,000 person study to attempt to settle doubts within the medical community about its value and potential consequences.
Prenuvo, the Redwood City, Calif.-based startup touted last year by Kim Kardashian, is one of a handful of companies selling preventive MRI scans: images that aim to catch conditions like cancer, brain aneurysms, autoimmune disorders, and metabolic issues before they advance. Scans range from $999 for a torso scan to about $2,500 for a whole-body image.
Prenuvo and its competitors, which include Ezra, Neko Health, and SimonMed, cater to patients who feel their concerns weren’t taken seriously enough by the traditional health care system and who are eager for more preventive care. But steep pricing and insurers’ resistance to covering these scans put them out of reach for the majority of Americans.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect